According to a recent Future Market Insights report, the market for malaria Ag rapid testing is forecast to register a compounded annual growth rate (CAGR) of 5% from 2023 to 2033. By the end of FY2023, a valuation of US$ 35 billion is anticipated for the market. At the end of the aforementioned forecast period, demand for malaria Ag rapid testing is slated to reach US$ 57 billion. With the increasing popularity of instant testing, the adoption of malaria Ag rapid testing is expected to receive a significant push.
According to the World Health Organization (W.H.O) World Malaria Report of 2021, there were an estimated 241 million malaria cases in 2020 in 85 malaria-endemic countries. This was an increase from 227 million in 2019, with most increases coming from countries in the W.H.O African region. As of 2021, there were an estimated 247 million cases globally. During the peak of the COVID-19 pandemic, cases rose by more than 13 million, with 63,000 deaths. This is pushing healthcare settings to provide advanced-grade treatments.
Over the past 2 decades, a slew of prevention measures has been undertaken, ranging from vector control and preventive chemotherapies to the administration of effective vaccines and early diagnoses and treatment. Among all approaches, the need for rapid testing has stood out, attracting a plethora of investments by notable market players, healthcare institutions, governments and other agencies.
Abbott Laboratories is a prominent player in the field of malaria Ag rapid testing. The company currently offers the BiolineTM Malaria Ag P.f/Pan test, which is a rapid, qualitative, and differential test for detecting histidine-rich protein 2 (HRP2) antigen of plasmodium falciparum, and common plasmodium lactate dehydrogenase (pLDH) of plasmodium species in human whole blood. The results are delivered in about 15-30 minutes of the testing duration. The kit demonstrates an overall sensitivity rate of over 99%.
On similar lines, Apacor offers the CAREUSTM Malaria RAPYDTEST, which isolates plasmodium falciparum HRP2 and pan-specific LDH on separate test lines. It consists of a user-friendly cartridge for ease of use and storage, and yield results in a time span of 20 minutes. Biosynex is yet another significant player, offering the BIOSYNEX® CellsCheck® test, with a sensitivity rate of 99.7%, used for detecting p. falciparum, parasitaemia, gametocytes and platelets. Results are declared in as little as 13 minutes.
Major providers of malaria Ag rapid testing are likely to find growth opportunities in the Asia Pacific. Reports claim that over 2 billion people across the 22 countries wherein malaria is highly prevalent, over 80% of the population is at risk of being infected with the disease. India carries the maximum burden, with over 24 million cases per year, followed by Indonesia, Pakistan, Myanmar, and Papua New Guinea. With the aim of completely eliminating the disease by 2030, the Asia Pacific Leaders Malaria Alliance is committed to providing effective and accessible treatment to infected patients. A major part of this would be to encourage the use of rapid testing kits to detect any suspected parasitic presence.
While the disease’s prevalence is largely negligible in the developed world, the United States is still expected to present many growth opportunities for malaria Ag rapid testing providers. While local outbreaks are relatively isolated, the country is grappling with “airport malaria”, the transmission of malaria rapidly in aircraft via infected mosquitos from a malaria-endemic country to a non-endemic country. Likewise, there have been cases of congenital malaria, wherein infected mothers carry the risk of transmitting the disease to their unborn children.
| Data Points | Key Statistics |
|---|---|
| Expected Market Value in 2023 | US$ 35 billion |
| Projected Market Value in 2033 | US$ 57 billion |
| Growth Rate (2023 to 2033) | CAGR of 5% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to the latest research by Future Market Insights, Malaria Ag rapid Testing Market is set to experience 5% growth during the year 2021-2031.
Malaria Ag rapid testing kits allows for quick detection of malarial antigen present in human body without the use of microscopes or in lab set-ups. Primary advantage of using a rapid testing kit is its ease of collection, cost effectiveness, safety and user friendly.
Malaria Ag rapid testing or rapid diagnostic test are lateral flow immunochromatographic antigen detection test, usually available in test strip or cassette form. These test detect the presence of malarial parasite antigen, in an infected human blood giving results within 15 minutes. Such procedures are simple, safe and easier for quick diagnosis of malaria at an initial stage and does not require special equipment or training.
An increasing number of cases of malaria in tropical countries along with increasing travelers visiting these countries, and in turn getting infected by malaria, can be seen rising in recent years.
Also the unavailability of lab testing for diagnosis of malaria in most endemic countries has further increased the necessity for the malaria antigen rapid tests. A per the 2019-20 report by World Health Organization (WHO), an estimated 229 Mn cases of malaria was found globally in 87 malaria-endemic countries in 2019.
Of which, 05 countries in Africa region namely, Nigeria (27%), the Democratic Republic of the Congo (12%), Uganda (5%), Mozambique (4%) and Niger (3%), accounted for about 51% of the global cases. Thus, the demand for the Malaria Ag rapid testing market is likely to provide incremental opportunity in the forecasted period.
Principal Consultant
The field of malaria Ag rapid testing market is witnessing series of advancements and is further expected to offer effective diagnostic solutions for infections caused by malaria. An increasing number of deaths caused due to non-diagnosis of malaria at early stages and increased resistance of parasite especially
P.falciparum to anti-malarial drugs has increased the need for these rapid diagnostic tests to diagnose the disease at the earliest and provide for treatment of same. As per the 2019-20 report by World Health Organization (WHO), 67% (274,000) of the total deaths caused by malaria, at global level, consisted of children below 5 years of age, in 2019.
Investment in malaria programs and research & development for malaria control and elimination are being undertaken by government and industry players in various regions. Various Public and private sector organizations are also playing major role in promoting and supporting the clinical development of key products.
A per the 2019-20 report by World Health Organization (WHO), an estimated US$ 3 Bn was the total funding provided for malaria control and elimination. Out of this total, US$ 900 Mn (31% of total funds) of funding was contributed by the government of endemic countries. It is thus, expected for the malaria Ag rapid test market to seek a growth in the forecasted period.
North America market growth is largely driven by the prevalence of “Airport” Malaria, a common term referring to the malarial infection caused due to the travelling population. Those who visit the malaria-endemic countries and in return get themselves exposed to the infection, resulting in transmission of the infection to the non-infected ones.
As per Centers for Disease Control and Prevention (CDC) report in 2019, approximately 2000 cases of malaria are detected every year in United States.
This is majorly due to increasing number of returning travelers and immigrants coming from countries where malaria transmission happened such as Sub Saharan Africa and South Asia.
Early detection of such cases can reduce future complications as well as risk of transmission associated with the infection. The FDA approved BinaxNOW rapid diagnostic test kit can test for malaria in an individual and help confirm the result.
Alternatively, various policy developments, scientific researches and initiatives, mosquito control programs undertaken by government to eliminate and to reduce the malaria transmission in this segment are expected to further improve the market scenario of Malaria Ag rapid testing.
With increasing number of malaria cases, it is believed to promote the growth of the malaria rapid testing market in the forecasted period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Europe is anticipated to be the largest market for Malaria Ag rapid testing. The continuous increase in business related/leisure travels, or migratory movements for employment to and from endemic countries have increased the chances of importing malaria to a malaria-free or non-endemic countries.
As per European Centre for Disease Prevention and Control (ECDC) Annual epidemiological report in 2019, 8641 cases of malarial were reported in Europe region, of which 99% of the cases were confirmed to be travel related infected malaria cases, while the rest 1% was acquired in the Europe.
A trend was observed in travel – related cases when the number of infections increase during or immediately after summer holidays (July –September).
The continuous efforts of government and private players in increasing the awareness about the control and management of malarial cases, growing research and development activities to diagnose malarial causing species in the European region which will further facilitate the growth of the market in the forecasted period.
Some of the key players of Malaria Ag rapid testing include
Companies offering Malaria Ag rapid testing are involved in existing product upgrades, new product launches, mergers and collaborations to enhance their market position.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments.
The report also maps the qualitative impact of various market factors on market segments and geographies.
Explore Healthcare Insights
View Reports
Malaria Ag Rapid Testing Market
